Oral iron absorption in hemodialysis patients treated with erythropoietin.

The effect of the erythropoietic activity of the bone marrow on oral iron absorption was investigated in hemodialysis patients. The subjects were enrolled in the Canadian Multicentre Erythropoietin (EPO) Trial; four patients were in the placebo group and four were in the EPO group. All patients were maintained iron replete with oral and intravenous iron as required to maintain ferritin greater than 200 micrograms/L. All patients had two oral …